Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague–Dawley rats
Keywords: DVS, desvenlafaxine succinate; MDD, major depressive disorder; VMS, vasomotor symptoms; 5-HT, serotonin; hSERT, human serotonin transporter; NE, norepinephrine; hNET, human norepinephrine transporter; DA, dopamine; hDAT, human dopamine transporter; SNRI,